Targeted protein quantitation and profiling using PVDF affinity probe and MALDI-TOF MS

Proteomics

Volumn 7, Issue 17, 2007, Pages 3038-3050

  Chen, Shu Hua ^a,b   Liao, Hsin Kai ^a   Chang, Chih Yang ^a   Juo, Chiun Gung ^c   Chen, Jenn Han ^d   Chan, Sunney I ^a,b   Chen, Yu Ju ^a,b,e  

^a INSTITUTE OF CHEMISTRY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

C reactive protein; Matrix assisted laser desorption ionization time of flight mass spectrometry; Quantitation; Serum amyloid A; Serum amyloid P

Indexed keywords

C REACTIVE PROTEIN; SERUM AMYLOID A; SERUM AMYLOID P; SIALIC ACID;

ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL PROTEOMICS; HUMAN; HYDROPHOBICITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ISOLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; SCREENING; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SYNTHESIS;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MEMBRANES, ARTIFICIAL; MODELS, BIOLOGICAL; POLYVINYLS; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SERUM AMYLOID A PROTEIN; SERUM AMYLOID P-COMPONENT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS;

EID: 34748858746     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700393     Document Type: Article

References (53)

1. Nedelkov, D., Kiernan, U. A., Niederkofler, E. E., Tubbs, K. A., Nelson, R. W., Investigating diversity in human plasma proteins. Proc. Natl. Acad. Sci. USA 2005, 102, 10852-10857.
2. Templin, M. F., Stoll, D., Schwenk, J. M., Potz, O. et al., Protein microarrays: Promising tools for proteomic research. Proteomics 2003, 3, 2155-2166.
3. Gelasco, A., Crouch, R. K., Knapp, D. R., Intrahelical arrangement in the integral membrane protein rhodopsin investigated by site-specific chemical cleavage and mass spectrometry. Biochemistry 2000, 39, 4907-4914.
4. Zenobi, R., Knochenmuss, R., Ion formation in MALDI mass spectrometry. Mass Spectrom. Rev. 1998, 17, 337-366.
5. Hutchens, T. W., Yip, T. T., New desorption strategies for the mass-spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom. 1993, 7, 576-580.
6. Nelson, R. W., Krone, J. R., Bieber, A. L., Williams, P., Mass-spectrometric immunoassay. Anal. Chem. 1995, 67, 1153-1158.
7. Tubbs, K. A., Nedelkov, D., Nelson, R. W., Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay. Anal. Biochem. 2001, 289, 26-35.
8. Kiernan, U. A., Nedelkov, D., Tubbs, K. A., Niederkofler, E. E., Nelson, R. W., Selected expression profiling of full-length proteins and their variants in human plasma. Clin. Proteomics 2004, 1, 7-16.
9. Kiernan, U. A., Addobbati, R., Nedelkov, D., Nelson, R. W., Quantitative multiplexed C-reactive protein mass spectrometric immunoassay. J. Proteome Res. 2006, 5, 1682-1687.
10. Papac, D. I., Hoyes, J., Tomer, K. B., Direct analysis of affinity-bound analytes by MALDI/TOF MS. Anal. Chem. 1994, 66, 2609-2613.
11. Brockman, A. H., Orlando, R., Probe-immobilized affinity chromatography/mass spectrometry. Anal. Chem. 1995, 67, 4581-4585.
12. Warren, E. N., Elms, P. J., Parker, C. E., Borchers, C. H., Development of a protein chip: A MS-based method for quantitation of protein expression and modification levels using an immunoaffinity approach. Anal. Chem. 2004, 76, 4082-4092.
13. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
14. Malik, G., Ward, M. D., Gupta, S. K., Trosset, M. W. et al., Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin. Cancer Res. 2005, 11, 1073-1085.
15. Diamandis, E. P., Mass spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations. Mol. Cell. Proteomics 2004, 3, 367-378.
16. Vestling, M. M., Fenselau, C., Surfaces for interfacing protein gel electrophoresis directly with mass spectrometry. Mass Spectrom. Rev. 1995, 14, 169-178.
17. Strupat, K., Karas, M., Hillenkamp, F., Eckerskorn, C., Lottspeich, F., Matrix-assisted laser-desorption ionization mass-spectrometry of proteins electroblotted after polyacrylamide-gel electrophoresis. Anal. Chem. 1994, 66, 464-470.
18. Vestling, M. M., Fenselau, C., Poly(vinylidene difluoride) membranes as the interface between laser-desorption mass-spectrometry, gel-electrophoresis, and in-situ proteolysis. Anal. Chem. 1994, 66, 471-477.
19. Jonsson, G. P., Hedin, A. B., Hakansson, P. L., Sundqvist, B. U. R. et al., Plasma desorption mass-spectrometry of peptides and proteins adsorbed on nitrocellulose. Anal. Chem. 1986, 58, 1084-1087.
20. Mock, K. K., Sutton, C. W., Cottrell, J. S., Sample immobilization protocols for matrix-assisted laser-desorption mass-spectrometry. Rapid Commun. Mass Spectrom. 1992, 6, 233-238.
21. Zaluzec, E. J., Gage, D. A., Allison, J., Watson, J. T., Direct matrix-assisted laser-desorption ionization mass-spectrometric analysis of proteins immobilized on nylon-based membranes. J. Am. Soc. Mass Spectrom. 1994, 5, 230-237.
22. Bai, J., Liu, Y. H., Cain, T. C., Lubman, D. M., Matrix-assisted laser desorption/ionization using an active perfluorosulfonated ionomer film substrate. Anal. Chem. 1994, 66, 3423-3430.
23. Blackledge, J. A., Alexander, A. J., Polyethylene membrane as a sample support for direct matrix-assisted laser-desorption ionization mass-spectrometric analysis of high-mass proteins. Anal. Chem. 1995, 67, 843-848.
24. Worrall, T. A., Cotter, R. J., Woods, A. S., Purification of contaminated peptides and proteins on synthetic membrane surfaces for matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 1998, 70, 750-756.
25. McComb, M. E., Oleschuk, R. D., Manley, D. M., Donald, L. et al., Use of a nonporous polyurethane membrane as a sample support for matrix-assisted laser desorption ionization time-of-eight mass spectrometry of peptides and proteins. Rapid Commun. Mass Spectrom. 1997, 11, 1716-1722.
26. Hung, K. C., Rashidzadeh, H., Wang, Y., Guo, B. C., Use of paraffin wax film in MALDI-TOF analysis of DNA. Anal. Chem. 1998, 70, 3088-3093.
27. Hung, K. C., Ding, H., Guo, B. C., Use of poly(tetrafluoroethylene)s as a sample support for the MALDI-TOF analysis of DNA and proteins. Anal. Chem. 1999, 71, 518-521.
28. Liang, X., Lubman, D. M., Rossi, D. T., Nordblom, G. D., Barksdale, C. M., On-probe immunoaffinity extraction by matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 1998, 70, 498-503.
29. Sun, S., Mo, W., Ji, Y., Liu, S., Use of nitrocellulose films for affinity-directed mass spectrometry for the analysis of antibody/antigen interactions. Rapid Commun. Mass Spectrom. 2001, 15, 1743-1746.
30. Xu, Y. D., Bruening, M. L., Watson, J. T., Non-specific, on-probe cleanup methods for MALDI-MS samples. Mass Spectrom. Rev. 2003, 22, 429-440.
31. Chang, C. Y., Liao, H. K., Juo, C. G., Chen, S. H., Chen, Y. J., Improved analysis of membrane protein by PVDF-aided, matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chim. Acta 2006, 556, 237-246.
32. Pepys, M. B., Dash, A. C., Markham, R. E., Thomas, H. C. et al., Comparative clinical-study of protein SAP (amyloid P-component) and C-reactive protein in serum. Clin. Exp. Immunol. 1978, 32, 119-124.
33. Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A. et al., Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 2002, 417, 254-259.
34. Jensen, L. E., Whitehead, A. S., Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 1998, 334, 489-503.
35. Juan, H. F., Chen, J. H., Hsu, W. T., Huang, S. C. et al., Identification of tumor-associated plasma biomarkers using proteomic techniques: From mouse to human. Proteomics 2004, 4, 2766-2775.
36. Chan, D. C., Chen, C. J., Chu, H. C., Chang, W. K. et al., Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann. Surg. Oncol. 2007, 14, 84-93.
37. Biran, H., Friedman, N., Neumann, L., Pras, M., Shainkin-Kestenbaum, R., Serum amyloid A (SAA) variations in patients with cancer: Correlation with disease activity, stage, primary site, and prognosis. J. Clin. Pathol. 1986, 39, 794-797.
38. Howard, B. A., Wang, M. Z., Campa, M. J., Corro, C. et al., Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics 2003, 3, 1720-1724.
39. Moshkovskii, S. A., Serebryakova, M. V., Kuteykin-Teplyakov, K. B., Tikhonova, O. V. et al., Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics 2005, 5, 3790-3797.
40. Berk, B. C., Weintraub, W. S., Alexander, R. W., Elevation of C-reactive protein in active coronary-artery disease. Am. J. Cardiol. 1990, 65, 168-172.
41. Patel, V. B., Robbins, M. A., Topol, E. J., C-reactive protein: A 'golden marker' for inflammation and coronary artery disease. Clevl. Clin. J. Med. 2001, 68, 521-534.
42. Berton, G., Cordiano, R., Palmieri, R., Pianca, S. et al., C-reactive protein in acute myocardial infarction: Association with heart failure. Am. Heart J. 2003, 145, 1094-1101.
43. Pepys, M. B., Hirschfield, G. M., C-reactive protein: A critical update. J. Clin. Invest. 2003, 111, 1805-1812.
44. Griselli, M., Herbert, J., Hutchinson, W. L., Taylor, K. M. et al., C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J. Exp. Med. 1999, 190, 1733-1740.
45. Tang, N., Tornatore, P., Weinberger, S. R., Current developments in SELDI affinity technology. Mass Spectrom. Rev. 2004, 23, 34-44.
46. Jang, J. S., Cho, H. Y., Lee, Y. J., Ha, W. S., Kim, H. W., The differential proteome profile of stomach cancer: Identification of the biomarker candidates. Oncol. Res. 2004, 14, 491-499.
47. Chou, P. H., Chen, S. H., Liao, H. K., Lin, P. C. et al., Nanoprobe-based affinity mass spectrometry for selected protein profiling in human plasma. Anal. Chem. 2005, 77, 5990-5997.
48. Lin, P. C., Chou, P. H., Chen, S. H., Liao, H. K. et al., Ethylene glycol-protected magnetic nanoparticles for a multiplexed immunoassay in human plasma. Small 2006, 2, 485-489.
49. Solakidi, S., Dessypris, A., Stathopoulos, G. P., Androulakis, G., Sekeris, C. E., Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and alpha 1-antitrypsin in patients with gastrointestinal malignancies. Clin. Biochem. 2004, 37, 56-60.
50. Ridker, P. M., High-sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention. Am. J. Cardiol. 2003, 92, 17-22.
51. Pepys, M. B., Rademacher, T. W., Amatayakulchantler, S., Williams, P. et al., Human serum amyloid-P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 1994, 91, 5602-5606.
52. Kiernan, U. A., Tubbs, K. A., Nedelkov, D., Niederkofler, E. E., Nelson, R. W., Detection of novel truncated forms of human serum amyloid A protein in human plasma. FEBS Lett. 2003, 537, 166-170.
53. Kiernan, U. A., Nedelkov, D., Tubbs, K. A., Niederkofler, E. E., Nelson, R. W., Proteomic characterization of novel serum amyloid P component variants from human plasma and urine. Proteomics 2004, 4, 1825-1829.